Apparatus and method for isolated lung access

Information

  • Patent Grant
  • 6398775
  • Patent Number
    6,398,775
  • Date Filed
    Thursday, October 21, 1999
    24 years ago
  • Date Issued
    Tuesday, June 4, 2002
    22 years ago
Abstract
Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.
Description




BACKGROUND OF THE INVENTION




1. Field of the Invention




The present invention relates generally to medical apparatus, systems, methods, and kits. More particularly, the present invention relates to methods and apparatus for isolating sub-bronchial regions of the lung and delivering or retrieving substances from such isolated regions.




Lung access and isolation is of interest in numerous therapeutic and diagnostic medical procedures. In particular, access to the lungs is useful for both local and systemic drug delivery, lung lavage, visual assessment and diagnosis of lung function, and the like.




For drug delivery, access is most simply achieved by introducing an aerosol to the lungs through the mouth or nose, and a variety of inhalers, nebulizers, metered dose inhalers (MDIs), nasal sprayers, and the like, have been developed over the years. While very effective for many drugs, delivery through the mouth or nose can be very inefficient, often with less than 20% of the drug reaching circulation or a targeted local treatment region. Moreover, inhalation through the mouth or nose is not able to target drug delivery to a particular region of the lungs. While this may not be a problem for systemic delivery, it can be a significant drawback in the treatment of localized disease where a highly controlled delivery profile would be preferred.




In an effort to overcome at least some of these shortcomings, a variety of endotracheal drug delivery and lung lavage systems have been developed. Most simply, an endotracheal or tracheostomy tube having an inflatable cuff at its distal end may be placed in a patient's trachea and used to deliver a drug aerosol to the whole of the lungs. While this can improve the efficiency of drug delivery (reducing the amount of drug deposited in the nasal passages or throat), it helps little in targeting treatment within any particular region of the lungs. Thus, it has been further proposed to use a secondary catheter placed through an endotracheal or tracheostomy tube for selectively isolating the left or right bronchus. For example, the secondary catheter can have an inflatable cuff which is positioned immediately beyond the main branching between the left and right bronchi. One of the bronchi can then be accessed through the secondary catheter while the other is accessed through the tracheal tube. Such systems are described, for example, in U.S. Pat. Nos. 5,285,778 and 5,660,175. While such systems offer significant benefits over the use of an endotracheal tube by itself, they still do not permit isolation of sub-bronchial regions of the lung for drug delivery, lavage, or any other purpose.




A system for bronchoalveolar lavage which can isolate a sub-bronchial region of the lung is described in published Application No. WO 92/10971. A co-axial catheter system is placed through an endotracheal tube, with the inner most catheter having an isolation wedge or balloon which can be positioned in a remote bronchiole to effect isolation of a distal region of the lung. The outer catheter has no capability for isolating the lung and is used, for example, for ventilating the lung proximal to the isolation cuff. While potentially an improvement over prior systems, the apparatus of WO 92/10971 will be very difficult to position, making targeting of particular sub-bronchial regions very difficult. Moreover, the inability to isolate a bronchus upstream from the distal isolation cuff limits the ability to selectively treat different regions of the bronchus in different ways. That is, while the particular sub-bronchial region which is isolated by the distal isolation cuff may be treated in one way, the remainder of that bronchus as well as the entire other lung must be ventilated and treated in a common manner through either the endotracheal tube or the outer catheter of the co-axial catheter pair.




For these reasons, it would be desirable to provide improved apparatus, systems, methods, and kits for the treatment and diagnosis of selected regions of a patient's lungs, particularly a lobar or targeted sub-lobar regions of the patient's lungs. The present invention should provide for the efficient delivery of pharmaceutical and other substances to the targeted sub-lobar regions of the lung. Moreover, in some embodiments, the present invention should be able to provide at least a second level of isolation within a particular bronchus and/or the ability to instill the pharmaceuticals or other substances at a point significantly distal to a point of isolation within the bronchus. The systems and apparatus of the present invention should be capable of being positioned precisely to a targeted bronchi within the bronchus, preferably providing on-board visualization while components of the system are positioned over a guidewire. Additionally, the apparatus, systems, methods, and kits of the present invention should be suitable for a wide variety of purposes, including pharmaceutical drug delivery, lung lavage (optionally in combination with drug delivery), diagnosis (optionally in combination with lung lavage), and the like. In particular, the present invention should be useful for localized drug delivery where a particular drug or other therapeutic agent can be delivered to a well-defined, isolated sub-bronchial region of the lung (as defined hereinafter) with little or no delivery to other regions of the lung. At least some of these objectives will be met by the inventions described hereinafter.




2. Description of the Background Art




WO 92/10971 describes a bronchoalveolar lavage catheter system having an outer catheter and an inner catheter with an enlarged (optionally inflatable) tip which is advanced until the tip wedges in a bronchiole of the patient. A region of the lungs distal to the enlarged tip may then be lavaged to retrieve sample. U.S. Pat. Nos. 5,660,175; 5,653,231; 4,716,896; and 4,453,545, describe single and co-axial catheter systems for accessing a patient's lungs. U.S. Pat. No. 5,285,778, describes a co-axial endoscopic lung access system. U.S. Pat. Nos. 5,309,903 and 5,207,220 describe systems for administering liquid pharmaceutical formulations to an isolated lung.




SUMMARY OF THE INVENTION




The present invention provides improved apparatus, systems, methods, and kits for isolating lobar and sub-lobar regions of a patient's lungs. The isolated region will be a portion (not the whole) of the right or left lung, and isolation will be accomplished by occluding a bronchial passage at at least one location in the lobar, segmental, and subsegmental bronchus. Thus, a primary occlusion will be formed after both the main bifurcation of the trachea and a further bifurcation into the lobar bronchus. Optionally, the lobar and/or sub-lobar region can be further isolated at at least one secondary location distal to the primary point of isolation and usually after further branching of the bronchial passages. Isolation at the primary location and optional additional locations within the bronchial passages will usually be effected by expansion of an occlusion member, such as an inflatable cuff, inflatable balloon, or the like.




Once the lobar or sub-lobar region has been isolated, a variety of therapeutic and diagnostic procedures can be performed within the isolated region. For example, pharmaceutical formulations including small molecule drugs, biological macromolecular drugs, and the like, can be specifically delivered to the isolated region with minimal or no cross-delivery to other regions of the lungs. Similarly, lavage may be performed within the isolated region with minimal impact on adjacent regions of the lungs. Isolation of the lobar or sub-lobar region permits such drug delivery and lavage procedures to be further controlled by control of the volumes, rates, pressures, temperatures, repetitions, retention times, and other method and system parameters. For example, the pressure within the isolated region can be controlled separately from the pressure or pressures maintained outside of the isolated region. In this way, a variety of delivery parameters can be controlled. By elevating pressure within the isolated region above that in the surrounding regions of the lung, the isolated lobar or sub-lobar region will be expanded which may, in some cases, enhance delivery of a drug or permit more efficient lavage of the region. Alternatively, by elevating pressure within the “other”lung regions above that within the isolated region, the risk of migration of toxic therapeutic or other agents away from the isolated region can be greatly reduced.




According to the present invention, an isolation catheter comprises a catheter body having a proximal end, a distal end, and a main lumen therebetween. An expansible occlusion member is disposed at or near the distal end of the catheter body, and optical and illumination fibers are disposed in the catheter body to permit imaging of a region distal to the distal end of the catheter body when the catheter is in use. Usually, a hub will be attached to the proximal end of the catheter and include at least one connection port for the main lumen of the catheter. Optionally, the hub will contain a second connection pert for the optical and illumination fibers, and may contain further connection ports for other lumens and capabilities of the catheter, as described hereinafter.




The catheter body of the isolation catheter will be adapted and sized to allow advancement of the distal end of the catheter body to a target bronchial passage within the lung which is located distal to a first branching of the right or left main stem bronchus. Usually, at least a distal region of the catheter body will have an outer diameter which is sufficiently small and flexible to be advanced into bronchioles having a diameter below about 12 mm, preferably below about 10 mm, and often below about 8 mm. Exemplary catheter bodies will have a length in the range from 40 cm to 150 cm, preferably from 50 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm, preferably from 3 mm to 6 mm, and a main lumen diameter in the range from 1 mm to 6 mm, preferably from 2 mm to 4 mm. The expansible occlusion member will typically be an inflatable cuff or balloon having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm. Usually, the catheter body will include at least one additional lumen for inflation of the inflatable cuff, and the additional lumen will be connected to an additional connector port on the catheter hub. Further optionally, the catheter body may include an additional lumen disposed to direct a washing fluid over a distal tip of the optical fiber which terminates at or near the distal end of the catheter body.




In a preferred aspect, systems according to the present invention comprises an isolation catheter as described above combined with an inner catheter to form a lung infusion/aspiration system. The inner catheter has a proximal end, a distal end, and a central lumen extending between the proximal end and distal end. The inner catheter is positionable within the main lumen of the isolation catheter so that the catheters may be used together in a co-axial fashion and further so that an annular lumen is formed within the main lumen of the isolation catheter, i.e., between an inner surface of the main lumen of the isolation catheter and an outer surface of the inner catheter. Optionally, the connector port on the isolation catheter has an additional connector port for the annular lumen. Alternatively, the system may comprise an adapter connectable to the hub on the isolation catheter, where the adapter has a connector port for the annular lumen. The dimensions and physical characteristics of the inner catheter will be chosen to permit introduction through the main lumen of the isolation catheter and farther to permit advancement of the inner catheter beyond the distal end of the isolation catheter into bronchial passages or bronchioles distal to the isolation catheter when in use.




An exemplary inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, preferably from 1.5 mm to 3.5 mm, an inner lumen diameter in the range from 0.1 mm to 3.5 mm, preferably from 1 mm to 3 mm, and a length which is at least 10 cm longer than the isolation catheter in the system. Typically, the inner catheter will have a length in the range from 50 cm to 200 cm, preferably from 60 cm to 110 cm. Optionally, the inner catheter may have an expansible occlusion member disposed near its distal end to permit selective isolation of a lobar or sub-lobar region between proximal and distal points along the bronchial passages of the lung. Typically, the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm.




When including an inflatable cuff, the inner catheter will usually further comprise an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff. Moreover, when provided with an inflatable cuff, the inner catheter will usually comprise an infusion/aspiration lumen having a distal port position proximally of the inflatable cuff so that substances, washing fluids, or the like, may be delivered or aspirated through the lumen between the inflatable cuff on the isolation catheter and the inflatable cuff on the inner catheter. Still further optionally, the inner catheter may comprise a vibratory element, such as an ultrasonic transducer, near its distal end to assist in dissolution of occlusive materials, enhance drug uptake, or the like. Still further optionally, the inner catheter may comprise two or more lumens, where at least two of the lumens are joined near a distal end to permit mixing of two or more gas or liquid streams which are being delivered through the catheter. The mixed streams are then released through a common outlet port on the inner catheter. Alternatively, the two streams may be delivered in parallel from the distal tip of the inner catheter for a variety of purposes.




The systems of the present invention may comprise further elements, such as guidewires, tracheal tubes with integral visualization (including both endotracheal and tracheostomy tubes), therapeutic or diagnostic reagents, and/or other system components intended to cooperate in performing the methods of the present invention as described in more detail below. Additionally, the systems of the present invention may be incorporated into kits where one or more system components are packaged together with instructions for use setting forth the methods described in more detail below. Such kits will usually further comprise packages for holding the system component(s) together with the instructions for use.




Methods according to the present invention comprise using an isolation catheter and an inner catheter (generally as described above) for isolating a lobar or sub-lobar region of the lung, and then performing a procedure within the isolated region. In a first instance, the methods are used for delivering a substance, typically a drug or other pharmaceutically active substance, to the isolated region. In a second instance, the methods are used for lavaging the isolated region, i.e., introducing and removing a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like, to the region. Optionally, the lavage and substance delivery methods can be combined where a drug or other active agent is included in the washing liquid which is being used for lavage. The methods of the present invention comprise positioning a distal end of the isolation catheter within a bronchial passage beyond a first branching within the right or left lung. The inner catheter is then positioned through the main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchial passage distally beyond the distal end of the isolation catheter. At least one occlusion element near the distal end of the isolation catheter is expanded within the bronchial passage to isolate a target lobar or sub-lobar region. Thereafter, in the case of drug or other substance delivery, the substance may be delivered through the inner catheter to the isolated region of the lung. In the case of lavage, the washing liquid may be infused through either (or both) of the inner catheter or the isolation catheter and aspirated through the other (or both) of the two catheters. Infusion and aspiration may be performed sequentially or concurrently, or in combinations of both sequential and concurrent infusion and aspiration. Often, it will be preferred to infuse the washing liquid through the inner catheter so that it enters the isolated region generally in a distal portion thereof and diffuses or migrates back toward the isolation catheter where it is collected and removed. In some instances, the washing liquid drug, or other substance may be introduced as a bolus and held or retained within the isolated sub-lobar region for a pre-selected retention time prior to initiating aspiration. In other instances, it may be desirable to continuously both infuse and aspirate the washing liquid drug, or other substance to get a “circulation” of the substance through the isolated lobar or sub-lobar region. Optionally, the washing liquid may comprise a d-rug or other biologically active substance to perform a therapeutic action while the region is being lavaged.




In the case of substance delivery, the substance may comprise any one of a wide variety of pharmaceutical agents, including small molecule drugs, protein drugs, carbohydrate drugs, nucleic acid drugs (genes, optionally in combination with delivery vectors and/or expression control segments), and the like. The delivered substances may be in the form of an aerosol, optionally produced within the inner catheter or prior to introduction to the inner catheter. Still further optionally, the substance may comprise a liquid which is instilled through the inner catheter. For both substance delivery and lavage, it will frequently be preferred to position the isolation catheter and inner catheter through a visualizing endotracheal or tracheostomy tube which has been previously placed in the patient's trachea. Suitable visualizing endotracheal tubes are described, for example, in U.S. Pat. No. 5,285,778, the full disclosure of which is incorporated herein by reference. Usually, a visualizing endotracheal or tracheostomy tube will include an inflatable cuff or other occlusion element so that the whole lungs may be isolated from the upper regions of the trachea. In this way, the patient may be ventilated through the tracheal tube while other regions of the lung are isolated. Moreover, direct visualization at the bifurcation between the left and right lungs helps position in place the isolation catheter to the target region to be isolated. Additionally, the regions of the lung above or proximal to the occlusion element on the isolation catheter may be ventilated and maintained at a different pressure through the tracheal tube. Thus, by employing isolation cuffs on the tracheal tube, the isolation catheter, and the inner catheter, at least three isolated zones within the lung may be maintained with different pressures being simultaneously maintained. Moreover, different substances can be delivered to each of these regions through the lumens of the inner catheter, isolation catheter, and the tracheal tube, respectively. Often, pressure within the isolated region may be maintained higher than that within the proximal regions of the lung (where pressure is being controlled through the tracheal tube) resulting in expansion of the isolated region which may be beneficial for a variety of reasons. Alternatively, pressure within the isolated region may be maintained below that of the proximal portions of the lung, reducing the risk of release of materials from the isolated region into the proximal portions of the lung. Moreover, when the inner catheter has an isolation cuff, a third distal region of the lung may be pressurized separately from the intermediate and proximal regions.




Introduction of the isolation catheter and/or inner catheter will preferably be performed over a guidewire. The guidewire will first be introduced to a point beyond the location in a bronchial passage where it is desired to position a distal end of the isolation catheter and/or inner catheter. Preferably the isolation catheter will comprise optical and illumination fibers which permit direct visual observation of the guidewire as the guidewire and isolation catheter are advanced. In particular, the guidewire and isolation catheter can be advanced in tandem so that, as successive bifurcations are approached, the physician can steer a curved end of the guidewire into the desired branch bronchial passage. Aft(r positioning the isolation catheter at its desired final location, an occlusion cuff may be expanded and the inner catheter optionally introduced over the guidewire or introduced directly through the main lumen of the isolation catheter without a guidewire. While the inner catheter may in some instances incorporate optical and illumination fibers, it will usually not have such imaging capabilities. Thus, positioning of the inner catheter will frequently be done solely by observation from the isolation catheter and/or under fluoroscopic or other external imaging. Of course, positioning of an isolation catheter can also be performed solely under fluoroscopic imaging (or in combination with both direct visual and fluoroscopic imaging), particularly when the isolation catheter does not include imaging capability.




In a further specific aspect of the methods of the present invention, the inner catheter may be moved and repositioned within the bronchial passages of the isolated region to deliver a substance or release a washing fluid for lavage at different points within the region. Optionally, the inner catheter can be moved (i.e., advanced distally or drawn proximally) while the substance or washing liquid is being released in order to better distribute the material within the isolated region. Further optionally, the inner catheter could also be moved through the isolated region in order to aspirate materials which have been introduced, either alone or in combination with aspiration through the main lumen of the isolation catheter.




Kits according to the present invention include at least an isolation catheter, and optionally include an inner catheter, a tracheal tube, and/or a guidewire. Other components including medical and bioactive reagents, e.g., drugs, washing liquids, or the like, may also be provided within the kits. In addition to the isolation catheter and optional other system components, the kits will comprise instructions for use setting forth a method of the present invention as generally set forth above. The kits will usually be packaged together in conventional medical packaging, such as a pouch, tray, tube, box, bag, or the like. Instructions for use may be provided on a separate printed sheet, or may printed in whole or in part on the packaging materials. When printed separately, the instructions are commonly referred to as a package insert. Usually, at least the isolation catheter and other components of the kit which would be used in the procedure will be packaged in a sterile manner within the kit.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a side view of a sub-lobar isolation catheter constructed in accordance with the principles of the present invention.





FIG. 1A

is a cross-sectional view taken along line


1


A—


1


A in FIG.


1


.





FIG. 1B

is an alternative cross-sectional view similar to that shown in FIG.


1


A.





FIG. 2

is a side view of a first alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.





FIG. 2A

is a cross-sectional view taken along line


2


A—


2


A of FIG.


2


.





FIG. 3

is a side view of a second alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.





FIG. 3A

is a cross-sectional view taken along line


3


A—


3


A of FIG.


3


.





FIG. 4

illustrates a system comprising a sub-lobar isolation catheter and an inner catheter constructed in accordance with the principles of the present invention.





FIG. 5

is a side view of the inner catheter of

FIG. 4

mounted within the sub-lobar isolation catheter, with portions broken away.





FIG. 6

illustrates a first alternative construction of the inner catheter of the resent invention.





FIG. 6A

is a cross-sectional view taken along line


6


A—


6


A of FIG.


6


.





FIG. 7

is a second alternative construction of the inner catheter of the resent invention.





FIG. 7A

is a cross-sectional view taken along line


7


A—


7


A of FIG.


7


.





FIG. 8

is a third alternative construction of the inner catheter of the present invention.





FIG. 8A

is a cross-sectional view taken along line


8


A—


8


A of FIG.


8


.





FIG. 8B

is a detailed view of the distal end of the catheter of

FIG. 8

taken along line


8


B—


8


B of FIG.


8


.





FIG. 9

is a fourth alternative construction of the inner catheter of the present invention.





FIG. 9A

is a cross-sectional view taken along line


9


A—


9


A of FIG.


9


.





FIG. 10

illustrates introduction of a sub-lobar isolation catheter to a diseased region within a lung according to the method of the present invention.





FIG. 11

is a detailed view of the introduction of

FIG. 10

shown with the isolation catheter being passed through a visualizing endotracheal tube.





FIGS. 12A-12C

illustrate use of the various inner catheters for performing particular procedures in accordance with the principles of the present invention.





FIG. 13

illustrates a kit constructed in accordance with the principles of the present invention.











DESCRIPTION OF THE SPECIFIC EMBODIMENTS




Isolation of a lobar or sub-lobar region of the lung is accomplished by occluding a lumen of a bronchial passage (bronchiole) at a location distal to a first branch in the network of bronchial passages within the right or left lung. Substances may be delivered to and/or a washing fluid may be used to lavage the isolated lobar or sub-lobar region of the lung by introducing or exchanging materials through a lumen of an isolation catheter, usually in combination with delivery or exchange through a lumen of an associated inner catheter. An inflatable cuff or other expansible isolation element on the isolation catheter is positioned at an isolation location within the bronchial passage, and the cuff inflated. The inner catheter is then positioned at a desired location distal to the end of the isolation catheter, and the isolated region is thus accessible through at least two access lumens, i.e., one lumen through the inner catheter and a second annular lumen between the exterior of the inner catheter and the interior luminal wall of the isolation catheter. These access lumens may be used separately or in combination in a variety of ways to perform the methods of the present invention. The apparatus and methods of the present invention will now be described in greater detail.




Referring to

FIGS. 1 and 1A

, an isolation catheter


10


comprises a catheter body


12


having a proximal end


16


and a distal end


14


. An inflatable isolation cuff


18


is disposed near the distal end


14


of the catheter body


12


, and an inflation lumen


20


extends through the catheter body from a proximal port


22


on proximal hub


24


to the balloon


18


. The catheter


10


further comprises an optical fiber or bundle


24


and an illumination fiber or bundle


26


, both of which are brought out to a suitable connector


28


through a connecting cable


30


. The optical fiber


24


and illuminating fiber


26


may be plugged into a variety of conventional imaging consoles which can provide a real time, visual image looking forwardly from the distal end


14


of the catheter body


12


. Suitable commercial imaging consoles are available from suppliers, such as Pulmon


x


, Palo Alto, Calif., assignee of the present application as well as Olympus, Pentax and Stryker. The catheter body


12


further includes a main lumen


32


which extends the entire length of the catheter body and passes through connector hub


36


to proximal connector


34


. As will be discussed in more detail below, the main lumen


32


can be used for introducing and/or aspirating materials which are introduced to or withdrawn from an isolated lobar or sub-lobar region of the lung. Most usually, the main lumen


32


will receive an inner catheter (

FIGS. 4 and 5

below), and the isolation catheter and inner catheter will be utilized together for delivering, collecting, and removing materials from an isolated sub-lobar region of the lung.




As shown in

FIGS. 1 and 1A

, the catheter body


12


of the isolation catheter


10


is a single extrusion having four lumens or passages formed therein. Two of the lumens form the inflation lumen


20


and the main lumen


32


, while the other two lumens house the optical fiber bundle


24


and the illumination fiber bundle


26


. The catheter body


12


could also be formed from a plurality of separate tubular members which are held together by an outer cover, as illustrated in FIG.


1


B. For example, an inner tube


40


can be disposed in parallel with the optical fiber bundle


24


and the illuminating fiber bundle


26


. A separate tubular member


42


can also be placed co-axially on the exterior of tube


40


, and all of the components held together by a cover


44


which may, for example, be shrink-wrapped over the assembly. An inflation lumen


46


is then provided in the space under the cover


44


which is unoccupied by the optical and tubular components. A variety of other specific construction designs may also be provided.




The catheter body


12


may be formed from conventional materials, such as polyamides (nylons), polyethylenes, polyurethanes, polytetrafluoroethylenes (PTFEs), polyimides, and the like. The inflatable cuff can be formed from other conventional materials, such as polyvinylchloride, polyurethanes, high density polyethylenes, low density polyethylenes, nylons, PTFEs, and the like. Exemplary and preferred dimensions for the catheter body


12


of the isolation catheter


10


have been set forth above.




A second exemplary isolation catheter


50


constructed in accordance with the principles of the present invention is illustrated in

FIGS. 2 and 2A

. The construction of isolation catheter


50


is generally the same as that for isolation catheter


10


, and like components will be given like numbers. The principal difference between the catheters


50


and


10


is that catheter


50


includes a lens washing lumen


52


which extends from lens washing port


54


in the hub


56


to a position at the distal tip of the catheter body which lies immediately over a lens (not shown) formed at the distal end of the optical fiber or bundle


26


. Because of the humid and contaminating nature of the lungs, it will be a significant benefit to be able to wash the optical viewing lens whenever the lens becomes obscured to do condensation or fouling.




A third exemplary construction of the isolation catheter of the present invention is illustrated in

FIGS. 3 and 3A

. There, an isolation catheter


60


comprises generally the same components as catheters


10


and


50


, except that catheter body


12


further includes a lumen


62


which receives a guidewire (or alternatively an articulating steering mechanism) and which extends from port


64


on hub


66


to the distal end


14


of the catheter body


12


. Thus, isolation catheter


60


is specially adapted for introduction over a guidewire (or other steering mechanism) according to the methods of the present invention and as described in more detail below. It will be appreciated, of course, that the earlier embodiments could also be introduced over a guidewire where the guidewire is passed through the main lumen


32


, but in such cases the main lumen would have to be emptied i.e., the inner catheter (if used) would have to be removed from the isolation catheter. Optionally, the isolation catheter


60


can also include a vibratory element


66


near its distal end. The vibratory element could be a mechanically driven surface, but will usually comprise an ultrasonic transducer intended to deliver vibratory energy to disrupt blockages in the bronchus, enhance drug delivery, or the like.




Systems


70


according to the present invention comprise an isolation catheter


10


(or any of the other isolation catheters described above or which would come within the principles of the present invention) and an inner catheter


80


. As illustrated in

FIGS. 4 and 5

, the inner catheter


80


is sized and adapted to fit within the main lumen


32


of the isolation catheter


10


. The inner catheter


80


has a distal end


82


and a proximal end


84


which terminates in a connecting hub


86


. The isolation catheter


10


includes a hub


96


which is similar to the previously described hubs, except that a proximal end has been modified to slidably receive the inner catheter


80


. As shown, an O-ring


90


is provided to provide a sliding pneumatic or hydraulic seal about the inner catheter. Additionally, an access port


92


is provided in the hub


96


to permit communication with the annular lumen


94


disposed between the exterior of inner catheter


80


and the interior of the main lumen


32


of the isolation catheter


10


. In this way, materials can be withdrawn or introduced through the isolation catheter


10


as well as through the lumen of the inner catheter


80


. More particularly, it permits two spaced-apart access points, i.e., at the distal ends of the isolation catheter


10


and inner catheter


80


, respectively, to be established within an isolated lobar or sub-lobar region of the lungs. Using two access points, a variety of substance delivery and lavage protocols can be run, as described in more detail below.




A first alternative embodiment of an inner catheter


100


is illustrated in

FIGS. 6 and 6A

. Inner catheter


100


includes catheter body


102


having an inflatable isolation cuff


104


near its distal end. A plurality of infusion/aspiration ports


106


are also formed near the distal end


103


of the catheter body


102


and are connected by a lumen


108


to an aspiration/infusion port


110


in proximal hub


112


. The inflatable cuff


104


may be inflated by connecting a suitable inflation source to connector


114


which delivers the inflation medium through lumen


116


to the cuff


104


. A central lumen


120


extends the length of the catheter body from its distal end


103


to a connection port


122


in the hub


112


. By providing the infusion/aspiration ports


106


proximal to the inflatable cuff


104


, it will be appreciated that substances may be delivered or removed from a region which is proximal to the cuff


104


but distal to the isolation cuff on the isolation catheter with which the inner catheter


100


is used.




Yet a further alternative embodiment of an inner catheter


130


is illustrated in

FIGS. 7 and 7A

. The inner catheter


130


includes an ultrasonic or other vibratory element


132


(shown in broken line) at or near its distal end


134


. The ultrasonic element


132


may be positioned at the distal end of a lumen


136


which extends through the length of the catheter


130


. The lumen


136


may thus hold wires necessary to power the ultrasonic transducer, where the wires are brought out through a connecting cable


140


and terminate in a plug


142


. An aspiration/infusion lumen


150


also extends the length of the catheter


130


and terminates in a luer or other connector


152


at the proximal end of the catheter. Optionally, a similar ultrasonic or other vibratory element may be disposed on the isolation catheter, either in addition to or in place of the vibration element


132


on the inner catheter. Although shown proximal to cuff


18


, the vibratory element


66


may also be placed distal to the cuff to deliver energy into an isolated region.




Referring now to

FIGS. 8

,


8


A, and


8


B, still a further embodiment of an inner catheter


160


will be described. The catheter


160


comprises a catheter body


162


having a distal end


164


and a proximal end


166


. A pair of lumens


168


and


170


extend the length of the catheter body


162


from ports


172


and


174


, respectively, and proximal hub of


176


to each of the lumens


168


and


170


is suitable for delivering a material, either liquid, aerosol, or solid (in some flowable form), from the ports


172


and


174


to a mixing region


180


near a distal instillation port


182


at a distal tip of the catheter. For example, air or other gas may be delivered through the larger lumen


170


so that it flows the mixing area


180


. By delivering a liquid or powder through the smaller lumen


168


, the airflow can act as a Venturi in suspending an aerosolizing material which is delivered to the mixing area. In this way, droplets or particulates can be delivered or instilled directly within an isolated lobar or sub-lobar region of the lung. By properly controlling the particulate or droplet size, i.e., to arrange generally between 0.1 μm to 5 μm, absorption of these materials into the alveolar regions of the lungs can be enhanced. By controlling the particulate or droplet size outside this range, usually above 5 μm, preferably above 10 μm, local delivery (i.e., not systemically absorbed) of a drag or other substance can be achieved.




Referring now to

FIGS. 9 and 9A

, still yet a further embodiment of an inner catheter


200


constructed in accordance with the principles of the present invention will be described. The inner catheter


200


comprises a catheter body


202


having a distal end


204


and a proximal end


206


. The catheter body includes a central lumen


210


and a pair of instillation lumens


212


and


214


. The catheter would be suitable for aerosolization of substances, particularly by delivering a liquid or solid powder substance through one of the lumens


212


and air or other aerosolization gas through the other lumen


214


. The central lumen


210


could be used for aspiration, delivery of other drug materials, or the like.




Referring now to

FIGS. 10

,


11


, and


12


A-


12


C, methods according to the present invention will be described. Most generally, an isolation catheter


10


may be introduced through the mouth, the trachea T and into a lobe L of the lung until it reaches a diseased region DR. Alternatively, the isolation catheter


10


could be introduced through an incision in the neck, usually through a tracheostomy tube. At that point, cuff


18


may be inflated to isolate regions of the lung distal to the inflated cuff in the bronchial passage. As illustrated in.

FIG. 11

, catheter


10


may optionally be delivered through a visualizing endotracheal tube VETT (or visualizing tracheostomy tube), where a cuff C on the tube is inflated within the trachea T at a region just above the main lung bifurcation into the right and left lungs RL and LL. Further optionally, the isolation catheter


10


may be advanced over a guidewire GW, where visualization of the guidewire immediately ahead of the catheter may be observed on the video screen V attached to the optical and illumination fibers within the catheter


10


. In particular, the guidewire may be advanced just ahead of the distal end of the catheter


10


in tandem so that the guidewire can be observed as it is rotated and introduced selectively into the bronchial passages at bifurcations. Alternatively, or additionally, advancement of the catheter


10


may be observed fluoroscopically or using any other available external imaging systems.




Once the catheter


10


is in place beyond a second bifurcation SB in the bronchial passages, as illustrated in

FIG. 12A

, the inflatable cuff


18


may be inflated to both anchor the distal end of the catheter and isolate regions of the lung distal thereto. After the cuff


18


is inflated, the inner catheter


80


may be advanced through the main lumen


34


so that the distal end


82


of the inner catheter progresses distally into a desired bronchial passage. Advancement of the distal end


82


may optionally be over a guidewire and will usually be performed under visual imaging using the optical illuminating fibers in the isolation catheter


10


. Once the inner catheter has been properly positioned, as shown in

FIG. 12B

, a desired procedure can be performed. For example, a drug can be delivered through the distal end


82


of the inner catheter to treat a target region TR, shown in broken line in

FIG. 12B

, additionally or alternatively, the target region TR can be lavaged by introducing a washing fluid through either catheter


10


or


80


and/or collecting the fluid through either of catheter


10


or


80


.




Alternatively, as shown in

FIG. 12C

, inner catheter


100


having inflatable cuff


104


at its distal end may be introduced through the isolation catheter


10


. By then inflating cuff


104


distally relative to cuff


18


on isolation catheter


10


, a modified target region MTR can be defined. In particular, the target region MTR in

FIG. 12C

will be more limited in volume than that formed in

FIG. 12B

where there is no distal isolation. Use of the second isolation cuff


104


on the inner catheter


100


permits much more specifically focused treatment protocols, both drug delivery and lavage, to be performed. By delivering or aspirating the materials through the ports


106


, it will be appreciated that the treatment is substantially limited to between the two cuffs


18


and


104


.




Referring now to

FIG. 13

, a kit


300


according to the present invention will comprise at least a lobar or sub-lobar isolation catheter


10


and an inner catheter


80


together with instructions for use IFU. Optionally, the kits may further include other system components as described above, such as a visualizing endotracheal tube VET, a guidewire GW, and/or various reagents (not shown). The instructions for use IFU will set forth any of the methods as described above, and all kit components will usually be packaged together in a suitable package


350


, such as a pouch, tray, tube, box, bag, or the like. Usually, those kits components, such as the isolation catheter


10


and inner catheter


80


, which will be used in performing the procedure on the patient, will be sterilized and maintained sterilely within the kit. Optionally, separate pouches, bags, trays, or other packaging materials may be provided within a larger package, where the smaller packs may be separately opened and will separately maintain the components in a sterile fashion.




While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.



Claims
  • 1. A method for delivering a substance to an isolated region of the lung, said method comprising:positioning a visualizing tracheal tube in a trachea; positioning a distal end of an isolation catheter through a lumen of the visualizing tracheal tube within a bronchial passage beyond a first branching within a right or left lung; positioning an inner catheter through a main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchiole distally beyond the distal end of the isolation catheter; expanding an occlusion element near the distal end of the isolation catheter within the bronchial passage to isolate a target region; providing a substance; and delivering the substance through the inner catheter to the isolated region of the lung.
  • 2. A method as in claim 1, wherein the substance comprises pharmaceutical.
  • 3. A method as in claim 1 or 2, wherein the substance comprises an aerosol or gas.
  • 4. A method as in claim 1 or 2, wherein the substance comprises a liquid.
  • 5. A method as in claim 1, further comprising aspirating the substance through the isolation catheter.
  • 6. A method as in claim 1, further comprising expanding an occlusion cuff on the visualizing tracheal tube and controlling ventilation of the patient's lungs through the visualizing tracheal tube.
  • 7. A method as in claim 6, wherein the isolated region and the remainder of the lung are maintained at different pressures.
  • 8. A method as in claim 7, wherein the pressure within the isolated region is maintained at a higher pressure than the remainder of the lung.
  • 9. A method as in claim 7, wherein the pressure within the isolated region is maintained at a lower pressure than the remainder of the lung.
  • 10. A method as in claim 1, further comprising positioning a guidewire to a point beyond the location in the bronchial passage where the occlusion element is to be expanded, wherein positioning the isolation catheter comprises introducing the isolation catheter over the guidewire.
  • 11. A method as in claim 10, further comprising viewing the guidewire using optical and illumination fibers carried by the isolation catheter as the guidewire is steered through bifurcations in the lungs.
  • 12. A method as in claim 10, further comprising viewing the guidewire fluoroscopically as the guidewire is steered through bifurcations in the lung.
  • 13. A method as in claim 1, further comprising drawing or advancing the inner catheter through the bronchiole while delivering the substance.
  • 14. A method as in claim 1, further comprising repositioning the inner catheter within the isolated region and delivering the substance to two or more locations.
  • 15. A method as in claim 1, further comprising expanding an occlusion element near the distal end of the inner catheter to isolate a distal portion of the bronchial passage so that an isolated region is disposed between the occlusion element on the isolation catheter and the occlusion element on the inner catheter.
  • 16. A method as in claim 15, wherein the substance is delivered through one or more delivering ports on the inner catheter proximal to the occlusion element.
  • 17. A method for lavaging an isolated region of a lung, said method comprising:positioning a visualizing endotracheal tube in a trachea; positioning a distal end of an isolation catheter through a lumen of the visualizing tracheal tube within a bronchial passage beyond a first branching within a right or left lung; positioning an inner catheter through a main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchiole distally beyond the distal end of the isolation catheter; expanding an occlusion element near the distal end of the isolation catheter within the bronchial passage to isolate a target region of the lung; infusing a washing liquid through one of the inner catheter or the isolation catheter to the isolated region of the lung; and aspirating the washing liquid from the isolated region through the other of the inner catheter or the isolation catheter.
  • 18. A method as in claim 17, wherein the washing liquid is infused through the inner catheter and aspirated through the isolation catheter.
  • 19. A method as in claim 17, wherein the washing liquid is infused through the isolation catheter and aspirated through the inner catheter.
  • 20. A method as in claim 17, wherein the washing liquid is alternately infused through the inner catheter and the isolation catheter and aspirated through the isolation catheter and the inner catheter.
  • 21. A method as in claim 17, wherein a bolus of the washing liquid is introduced and held within the isolated region for a retention time period prior to initiating aspiration.
  • 22. A method as in claim 17, wherein the infusing and the aspirating of the washing liquid are performed simultaneously.
  • 23. A method as in claim 17, wherein the washing liquid comprises a pharmaceutical substance.
  • 24. A method as in claim 17, further comprising expanding an occlusion cuff on the visualizing tracheal tube and ventilating the patient's lungs through the visualizing tracheal tube at a controlled pressure.
  • 25. A method as in claim 24, further comprising controlling pressure of the target isolated region, wherein the isolated region and the remainder of the lung may be controlled at different pressures.
  • 26. A method as in claim 25, wherein the pressure within the isolated region is maintained at a higher pressure than the remainder of the lung.
  • 27. A method as in claim 25, wherein the pressure within the isolated region is maintained at a lower pressure than the remainder of the lung.
  • 28. A method as in claim 17, further comprising positioning a guidewire to a point beyond the location in the bronchial passage where the occlusion element is to be expanded, wherein positioning the isolation catheter comprises introducing the catheter over the guidewire.
  • 29. A method as in claim 28, further comprising viewing the guidewire using optical and illumination fibers carried by the isolation catheter as the guidewire is steered through bifurcations in the lungs.
  • 30. A method as in claim 28 further comprising viewing the guidewire fluoroscopically as the guidewire is steered through bifurcations in the lung.
  • 31. A method as in claim 17, further comprising drawing or advancing the inner catheter through the bronchiole while delivering the washing liquid.
  • 32. A method as in claim 17, further comprising repositioning the inner catheter within the isolated region and delivering the washing liquid to two or more locations.
  • 33. A method as in claim 17, further comprising expanding an occlusion element near the distal end of the inner catheter to isolate a distal portion of the bronchial passage so that the isolated region is disposed between the occlusion element on the isolation catheter and the occlusion element on the inner catheter.
  • 34. A method as in claim 33, wherein the washing liquid is delivered through one or more delivering ports on the inner catheter proximal to the occlusion element.
US Referenced Citations (8)
Number Name Date Kind
4453545 Inoue Jun 1984 A
4714460 Calderon Dec 1987 A
4716896 Ackerman Jan 1988 A
5207220 Long May 1993 A
5285778 Mackin Feb 1994 A
5309903 Long May 1994 A
5653231 Bell Aug 1997 A
5660175 Dayal Aug 1997 A
Foreign Referenced Citations (1)
Number Date Country
WO 9210971 Jul 1992 WO